Skip to content
Stock screener

PASW Ping An Biomedical Co., Ltd. stock chart & analysis

Conviction 40Scan · Fri, Nov 6, 2026

Ping An Biomedical Co., Ltd. (PASW) closed at $1.31 (-17.61%) on Nov 6, 2026. Price is below its 50-day and below its 200-day moving average. RSI(14) 27, RS Rating 2, -95.5% from its 52-week high, -93.6% year to date.

PASW$1.31-17.61%
ResistanceSupportVol 14
Loading chart…
Price1.31
Change-17.61%
Gap+0.63%
Rel volume1.16×
Avg volume79.18K
Avg $ vol297.74K
SMA 204.44
SMA 504.90
SMA 2006.00
Price vs 50-73.67%
Price vs 200-78.51%
MA stackbearish
50/200 cross—
Supertrenddown · 4.90
RSI (14)27
MACD hist-0.36
MACD crossbear · 2d
Stoch %K / %D2 / 9
ADX (14)26
+DI / −DI14 / 28
RSI divergence—
MACD divergence—
ATR %83.53%
ADR %29.78%
52w high28.56
52w low1.18
From 52w high-95.48%
Above 52w low+9.32%
New 52w highNo
SqueezeOff
Bollinger width102.73%
%B-0.19
Donchian pos2.17%
Donchian high6.25
Donchian low1.18
AVWAP (52w high)7.71
vs AVWAP high-83.26%
AVWAP (52w low)1.36
vs AVWAP low-4.91%
OBV trendDown
Chaikin MF (20)-0.08
Today vs 20d1.16×
Avg vol (14d)110.98K
Avg vol (20d)79.18K
Avg $ vol (20d)297.74K
Market cap20.82M
RS Rating2 / 99
RS 3m (vs SPY)-70.70%
RS 6m (vs SPY)-78.48%
RS line new highNo
Trend template0/8
Technical rank2.7
1 week-74.80%
1 month-71.93%
3 months-75.57%
6 months-78.78%
1 year-94.80%
YTD-93.57%
P/E—
P/B—
P/S—
P/FCF—
EPS—
Div yield—
ROE—
ROA—
Debt/Eq0.22
Current2.76
EV/EBITDA—
Gross margin—
Net margin—
Rev growth—
EPS growth—
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value—
Revenue—
Net income—
Gross profit—
Free cash flow—
Industry—
ExchangeNasdaq
Shares out—
Employees7
ListedFri, Jul 18, 2025
Free float9.13M
Float %44.6%
Short interest—
Days to cover—
Short volume50.7%
Squeeze score—
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction40 / 100
Pattern quality—
Tech rank2.7 / 100
Group rank—
Status laneNo active setup
Setup direction—
Pattern family
Resistance6.29
Support3.70
Days since event—
Candle confirm—

PASW technical analysis

Trend

PASW is in a downtrend: price is below the 50-day, which is below the 200-day moving average. It closed 73.7% below the 50-day ($4.90) and 78.5% below the 200-day ($6.00). ADX(14) at 26 points to a strong, established trend. It meets 0 of 8 trend-template criteria.

Momentum

RSI(14) is 27, in oversold territory. MACD crossed below its signal line 2 sessions ago. Its RS Rating of 2 puts its weighted 12-month performance ahead of about 2% of the US market.

Volume and volatility

Volume on the latest session ran 1.2× its 20-day average. It trades about $297,741 a day on average. ATR(14) is $1.08, 83.5% of price — its typical daily range. On-balance volume is trending down. Chaikin Money Flow (-0.08) shows distribution.

Key levels

The chart pattern's support is $3.70 and its resistance $6.29. The 52-week range is $1.18 to $28.56; price is 95.5% below the high and 9.3% above the low. The VWAP anchored at the 52-week high is $7.71, above price.

Performance

PASW returned -74.8% (1 week), -71.9% (1 month), -75.6% (3 months), -78.8% (6 months), -94.8% (1 year), -93.6% (year to date).

About Ping An Biomedical Co., Ltd.

Ping An Biomedical Co Ltd formerly Majestic Ideal Holdings Ltd is a Cayman Islands-based holding company, conducting operations through its PRC subsidiary, NewBrand. The group is a provider of SCM services in the apparel industry, offering solutions for a broad range of yarn products, textiles, and finished garments. Its service offerings encompass every key aspect of the supply chain of textile products, such as market trend analysis, product design and development, raw material sourcing, production and quality control, and logistics management. The group has two reportable segments, yarns and finished garments. The majority of its revenue is generated from the sale of yarns, including pure cashmere and cashmere-mix yarn, merino wool, cotton, and fancy yarn.

Listed 2025 · 7 employees

SEC filings

EDGAR filings in PASW · 9 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, no credit card.

Start free — 7-day trial, no card →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.